Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer/Pharmacia Sales Force Debuts In June; Inspra Launch Delayed

Executive Summary

The restructured Pfizer/Pharmacia sales force will begin operations in June

You may also be interested in...



Pfizer/Boehringer Spiriva Clears FDA For COPD; Launch Set For Summer

Pfizer/Boehringer Ingelheim's marketing plan for Spiriva will emphasize the drug's long-term efficacy compared to other COPD therapies

Pfizer Could Launch Three Significant NMEs in 2004; Will Any Surpass Viagra?

Pfizer's product outlook is brightening in 2004, with the launch of three commercially significant new molecular entity products on the horizon

Pfizer Could Launch Three Significant NMEs in 2004; Will Any Surpass Viagra?

Pfizer's product outlook is brightening in 2004, with the launch of three commercially significant new molecular entity products on the horizon

Related Content

UsernamePublicRestriction

Register

OM006051

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel